Leptica 75mg capsules
Ingredients in every capsule
Each package contains
|ATC Level 1:||N - Nervous system|
|ATC Level 2:||N03 - Antiepileptics|
|ATC Level 3:||N03A - Antiepileptics|
18 TO 65 YEARS OLD
The dose range is 150 to 600 mg per day given in either two or three divided doses, pregabalin is given with or without food.
The recommended starting dose for pregabalin is 150 mg per day given as two or three divided doses. Based on individual patient response and tolerability, the dose may be increased to 300 mg per day after an interval of 3 to 7 days, and if needed, to a maximum dose of 600 mg per day after an additional week.
The recommended effective starting dose for pregabalin is 150 mg per day given as two or three divided doses. Based on individual patient response and tolerability, the dose may be increased to 300 mg per day after 1 week, and if needed, to a maximum dose of 600 mg per day may be achieved after an additional week.
Generalized anxiety disorder
The dose range is 150 to 600 mg per day given as two or three divided doses. The need for treatment should be reassessed regularly.
Pregabalin treatment can be started with a dose of 150 mg per day. Based on individual patient response and tolerability, the dose may be increased to 300 mg per day after 1 week. Following an additional week the dose may be increased to 450 mg per day. The maximum dose of 600 mg per day may be achieved after an additional week.
Discontinuation of pregabalin
In accordance with current clinical practice, if pregabalin has to be discontinued, it is recommended this should be done gradually over a minimum of 1 week independent of the indication.
0 TO 18 YEARS OLD
The use in children is not recommended.
65 YEARS OLD AND ABOVE
Elderly patients may require a dose reduction of pregabalin due to a decreased renal function.
No dose adjustment is required for patients with hepatic impairment.
Pregabalin is eliminated from the systemic circulation primarily by renal excretion as unchanged drug. As pregabalin clearance is directly proportional to creatinine clearance, dose reduction in patients with compromised renal function must be individualized according to creatinine clearance (Clcr).
− Neuropathic pain
Pregabalin is indicated for the treatment of peripheral and central neuropathic pain in Adults.
Pregabalin is indicated as adjunctive therapy in Adults with partial seizures with or without secondary generalization.
− Generalized anxiety disorder
Pregabalin is indicated for the treatment of generalized anxiety disorder (GAD) in Adults.
All of the content present on this website, including written text, photographs, videos, graphics, and other resources we might include (these will fall under the collective term of “website”), is meant to educate and should not be perceived as a substitution for professional medical advice, diagnosis or treatment. You should not resort to the website information to arrive at a diagnosis or treatment solution for your health problems or various medical conditions. It does not replace medical care, provided by a medical specialist. In the situation, you have specific symptoms and you might suspect that you are suffering from a medical problem, it is for the best to consult your physician.